Info@ThinkPinkRocks.com

FDA grants orphan drug designation for neuroblastoma vaccine

The U.S. Food and Drug Administration granted orphan drug designation for a neuroblastoma vaccine from MabVax Therapeutics, providing development incentive with market exclusivity of the novel treatment for children with this deadly childhood cancer.

Read the article:
FDA grants orphan drug designation for neuroblastoma vaccine

Share

Leave a Reply